WST — WEST PHARMACEUTICAL SERVICES INC

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 105770 ·
Last close
$414.12
Market Cap
$28.85B
52W High
$437.99
52W Low
$223.37
ADV30
663,299
Next earnings
2026-10-29

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 874,500,000 347,400,000 216,200,000 214,000,000 4,060,700,000 464,100,000 1,092,500,000
Jun 2026 872,300,000 329,200,000 191,900,000 154,000,000 4,076,400,000 435,800,000 1,086,200,000
Mar 2026 844,900,000 296,400,000 181,100,000 138,800,000 4,109,800,000 521,400,000 1,119,400,000
Dec 2025 805,000,000 303,900,000 175,100,000 132,100,000 4,270,000,000 791,300,000 1,094,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$654,500,000
Investing CF
$-83,100,000
Financing CF
$-727,000,000
CapEx
$-201,100,000
Dividends Paid
$-62,800,000
Buybacks
$-689,300,000
EPS Diluted TTM
$8.91
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$4,816,800,000
Inventory
$464,700,000
Receivables
$748,200,000
ST Investments
—
EBIT TTM
$797,500,000
Pretax Income TTM
$789,400,000
Interest Exp TTM
$8,100,000
Analysts
15

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,396,699,904
EBITDA
$963,500,032
Free Cash Flow
$353,087,488
Enterprise Value
$28,641,775,616
Total Cash
$464,100,000
Total Debt
$305,000,000
Shares Out
69,661,036
Trailing EPS
$7.81
Book Value
$42.47
ROE
21.2%
ROA
11.9%
Div Yield
0.25%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 3,074,100,000 636,100,000 493,700,000 4,270,000,000 1,094,000,000 3,176,000,000 754,800,000
Dec 2024 2,893,200,000 590,900,000 492,700,000 3,643,400,000 961,100,000 2,682,300,000 653,400,000
Dec 2023 2,949,800,000 707,400,000 593,400,000 3,829,500,000 948,500,000 2,881,000,000 776,500,000
Dec 2022 2,886,900,000 760,800,000 585,900,000 3,616,800,000 931,900,000 2,684,900,000 724,000,000

TTM Snapshot

Revenues TTM
$3,326,800,000
NetIncome TTM
$564,900,000
OpCashFlow TTM
—
Assets (Latest)
$4,076,400,000
Forward EPS
$9.98

Max Pain — expiry 2026-12-18

max pain strike: $330.00 · spot: $404.02 · call oi: 873 · put oi: 1,264
Expected Move to 2026-12-18: ±$23.70 (5.87%) — implied range $380.32 – $427.72 · ATM straddle on $400.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PHG KONINKLIJKE PHILIPS NV $29.22B $29.89 —
DXCM DEXCOM INC $30.60B $82.04 —
FSNUF Fresenius SE & Co. KGaA $26.39B $46.86 —
MDLN Medline Inc. $33.11B $37.68 —
STE STERIS plc $25.00B $257.41 —

News headlines (Yahoo Finance, 1h cache)

West Pharmaceutical Services (WST) Stock May Be 29% Overvalued On Cash Flow Views
2026-11-13 12:14 · Yahoo
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
2026-11-18 16:57 · Yahoo
GE HealthCare Expands Global Research Network for Photon-Counting CT
2026-11-18 16:54 · Yahoo
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now
2026-11-18 11:24 · Yahoo
Ecolab Launches Integrated Cooling Platform to Tap AI Growth
2026-11-17 15:47 · Yahoo
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
2026-11-17 12:37 · Yahoo
Can Insulet Stock Jump 50%?
2026-11-16 23:20 · Yahoo
DOCS Expands Clinical AI Tools Across Three Major U.S. Health Systems
2026-11-16 16:27 · Yahoo
Here's Why You Should Retain PHG Stock in Your Portfolio for Now
2026-11-16 14:13 · Yahoo
GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research
2026-11-13 15:36 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.